In a mouse model of melanoma, dual therapy with antigen‐specific TCs co‐incubated with aAPCs and injection of anti‐PD‐1 Ab resulted in a significant increase in the activation of the TCs and increased animal survival. Here, PDCD1 is linked to melanoma.